![]() ThermoGenesis ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. | ![]() CF PharmTech CF PharmTech (长风药业股份有限公司) is a specialty pharmaceutical company focused on the development and manufacturing of inhalation products. | ![]() Balmes Transplantation Balmes Transplantation is a pharmaceutical company focused on kidney ischemia-reperfusion injury (IRI), including acute kidney injury and kidney transplantation. | |||
Founding Date | Founding Date 2009 | Founding Date 2019 | Founding Date 1986 | Founding Date 2007 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Mississauga, CA HQ | Locations New York, US HQ | Locations Rancho Cordova, US HQ Wuxi Shi, CN | Locations Suzhou Shi, CN HQ Nanjing Shi, CN Wuxi Shi, CN City Of Industry, US | Locations Marseille, FR HQ |
Employees | Employees 814% increase | Employees 313% increase | Employees 5338% decrease | Employees 294% increase | Employees 3 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 5m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 50m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 10.6m | Total funding raised $ 15m | Total funding raised $ 205.4m | Total funding raised N/A |

Ordaōs Bio is a company that develops human-enabled machine-driven design drugs.
View company
ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
View company
CF PharmTech (长风药业股份有限公司) is a specialty pharmaceutical company focused on the development and manufacturing of inhalation products.
View company
Balmes Transplantation is a pharmaceutical company focused on kidney ischemia-reperfusion injury (IRI), including acute kidney injury and kidney transplantation.
View company